The use of tamsulosin and iris hypotony during cataract surgery.
Pärssinen
Olavi
O
D058668:Adrenergic alpha-1 Receptor Antagonists; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007498:Iris / Q000187:drug effects*; D008297:Male; D018918:Phacoemulsification; D011391:Prolapse; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D011681:Pupil Disorders / Q000139:chemically induced*; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D000077409:Tamsulosin
D058668:Adrenergic alpha-1 Receptor Antagonists; D000970:Antineoplastic Agents; D013449:Sulfonamides; D000077409:Tamsulosin